Skip to main content
Top
Published in: Supportive Care in Cancer 8/2019

01-08-2019 | Acute Promyelocytic Leukemia | Commentary

Pain and related complaints in patients with acute leukemia: time for simultaneous care in hemato-oncology

Authors: Pasquale Niscola, Andrea Tendas, Carla Mazzone, Fabio Efficace

Published in: Supportive Care in Cancer | Issue 8/2019

Login to get access

Abstract

This commentary deals with the need of an early integration between hematologist and palliative care specialists as well as pain therapists as a routine basis in order to ensure the best management of patients affected by acute leukemia from the onset of the disease and in the stages of causal therapy. This strategy could limit the burden of painful symptoms and, in addition, avoid unnecessary suffering to patients, ensuring the best conditions for optimal outcome of these patients with extremely high clinical complexity and symptomatology who receive intensive treatments or who are managed with novel treatment approaches.
Literature
1.
go back to reference Niscola P, Cartoni C, Romani C, Brunetti GA, D’Elia GM, Cupelli L, Tendas A, de Fabritiis P, Mandelli F, Foà R (2007) Epidemiology, features and outcome of pain in patients with advanced hematological malignancies followed in a home care program: an Italian survey. Ann Hematol 86:671–676CrossRefPubMed Niscola P, Cartoni C, Romani C, Brunetti GA, D’Elia GM, Cupelli L, Tendas A, de Fabritiis P, Mandelli F, Foà R (2007) Epidemiology, features and outcome of pain in patients with advanced hematological malignancies followed in a home care program: an Italian survey. Ann Hematol 86:671–676CrossRefPubMed
2.
go back to reference Niscola P, Romani C, Cartoni C, Cupelli L, Piccioni D, Dentamaro T, Tendas A, Giovannini M, Scaramucci L, Tolu B, Perrotti AP, de Fabritiis P (2008) Epidemiology of pain in hospital haematological setting: an Italian survey. Leuk Res 32(1):197–198CrossRefPubMed Niscola P, Romani C, Cartoni C, Cupelli L, Piccioni D, Dentamaro T, Tendas A, Giovannini M, Scaramucci L, Tolu B, Perrotti AP, de Fabritiis P (2008) Epidemiology of pain in hospital haematological setting: an Italian survey. Leuk Res 32(1):197–198CrossRefPubMed
3.
go back to reference Zimmermann C, Yuen D, Mischitelle A, Minden MD, Brandwein JM, Schimmer A, Gagliese L, Lo C, Rydall A, Rodin G (2013) Symptom burden and supportive care in patients with acute leukemia. Leuk Res 37(7):731–736CrossRefPubMedPubMedCentral Zimmermann C, Yuen D, Mischitelle A, Minden MD, Brandwein JM, Schimmer A, Gagliese L, Lo C, Rydall A, Rodin G (2013) Symptom burden and supportive care in patients with acute leukemia. Leuk Res 37(7):731–736CrossRefPubMedPubMedCentral
4.
go back to reference Niscola P, Tendas A, Scaramucci L et al (2011) Pain in malignant hematology. Expert Rev Hematol 4(1):81–93CrossRefPubMed Niscola P, Tendas A, Scaramucci L et al (2011) Pain in malignant hematology. Expert Rev Hematol 4(1):81–93CrossRefPubMed
5.
go back to reference Getz KD, Miller TP, Seif AE et al (2018) Opioid utilization among pediatric patients treated for newly diagnosed acute myeloid leukemia. PLoS One; 8 13(2):e0192529CrossRefPubMedPubMedCentral Getz KD, Miller TP, Seif AE et al (2018) Opioid utilization among pediatric patients treated for newly diagnosed acute myeloid leukemia. PLoS One; 8 13(2):e0192529CrossRefPubMedPubMedCentral
7.
go back to reference Efficace F, Breccia M, Avvisati G, Cottone F, Intermesoli T, Borlenghi E, Carluccio P, Rodeghiero F, Fabbiano F, Luppi M, Romani C, Sborgia M, D’Ardia S, Nobile F, Cantore N, Crugnola M, Nadali G, Vignetti M, Amadori S, Lo Coco F (2018) Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemia. Leukemia. https://doi.org/10.1038/s41375-018-0325-4 Efficace F, Breccia M, Avvisati G, Cottone F, Intermesoli T, Borlenghi E, Carluccio P, Rodeghiero F, Fabbiano F, Luppi M, Romani C, Sborgia M, D’Ardia S, Nobile F, Cantore N, Crugnola M, Nadali G, Vignetti M, Amadori S, Lo Coco F (2018) Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemia. Leukemia. https://​doi.​org/​10.​1038/​s41375-018-0325-4
8.
go back to reference Niscola P, Tendas A, Efficace F (2018) Early palliative care in patients with hematological malignancies: where do we go from here? J Pain Symptom Manag 55(4):e1–e2CrossRef Niscola P, Tendas A, Efficace F (2018) Early palliative care in patients with hematological malignancies: where do we go from here? J Pain Symptom Manag 55(4):e1–e2CrossRef
9.
go back to reference Boucher NA, Johnson KS, LeBlanc TW (2018) Acute leukemia patients’ needs: qualitative findings and opportunities for early palliative care. J Pain Symptom Manag 55(2):433–439CrossRef Boucher NA, Johnson KS, LeBlanc TW (2018) Acute leukemia patients’ needs: qualitative findings and opportunities for early palliative care. J Pain Symptom Manag 55(2):433–439CrossRef
10.
go back to reference Wadhwa D, Popovic G, Pope A, Swami N, Le LW, Zimmermann C (2018) Factors associated with early referral to palliative care in outpatients with advanced cancer. J Palliat Med 21(9):1322–1328CrossRefPubMed Wadhwa D, Popovic G, Pope A, Swami N, Le LW, Zimmermann C (2018) Factors associated with early referral to palliative care in outpatients with advanced cancer. J Palliat Med 21(9):1322–1328CrossRefPubMed
Metadata
Title
Pain and related complaints in patients with acute leukemia: time for simultaneous care in hemato-oncology
Authors
Pasquale Niscola
Andrea Tendas
Carla Mazzone
Fabio Efficace
Publication date
01-08-2019
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 8/2019
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-04743-y

Other articles of this Issue 8/2019

Supportive Care in Cancer 8/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine